MedTrace Logo

Development of Fecal Scoring for the Management of Fecal Impaction With Regards to Lower Urinary Tract Dysfunction

NCT04579731 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 187

Last updated 2021-08-10

No results posted yet for this study

Summary

The role of bowel bladder disorder, or BBD, has been highlighted as a major player in vesicoureteral reflux and urinary tract infection (UTI). However, the diagnosis of BBD are still conceptual and subjective, because of the diagnosis of constipation, main pathophysiology in BBD has not been established well.

Conditions

  • Fecal Impaction
  • Lower Urinary Tract Disorder
  • Bladder Dysfunction
  • Bowel Dysfunction

Interventions

DRUG

Lactitol Monohydrate

Patients with lower urinary tract dysfunction and assumed to have constipation were placed on lactitol monohydrate 10 g for 8 weeks, and had re-evaluated.

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Kwanjin Park, M.D. Ph.D · Seoul National University Hospital

Eligibility

Min Age
5 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-25
Primary Completion
2021-06-02
Completion
2021-06-02

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04579731 on ClinicalTrials.gov